Reuters -- Shares in biopharmaceutical company Anthera Pharmaceuticals Inc (ANTH.O) closed 1 cent above their initial public offering price on Monday, in a postponed and downsized deal.
Reuters -- Shares in biopharmaceutical company Anthera Pharmaceuticals Inc (ANTH.O) closed 1 cent above their initial public offering price on Monday, in a postponed and downsized deal.